Cystic Fibrosis in Children Clinical Trial
— PHACTS-CFOfficial title:
Investigating Physical Activity Levels of Parents of Children With Cystic Fibrosis and Its Influence on Their Children's Physical Activity Levels and Nebuliser Use
This study will investigate if parental physical activity levels, assessed by providing a physical activity questionnaire to parents of children aged 6-16 with Cystic Fibrosis (CF), is associated with their child with CF's physical activity levels. Children's activity levels will be taken from electronic records where a questionnaire is routinely given at annual reviews to analyse this. Parental activity levels will also be compared against adherence to nebulisers as a proxy for adherence to treatment, this data is again in the electronic records of patients and is collected at annual reviews.
Status | Not yet recruiting |
Enrollment | 30 |
Est. completion date | October 1, 2023 |
Est. primary completion date | October 1, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 5 Years to 16 Years |
Eligibility | Inclusion Criteria: 1. Parents of Children aged 5-16 years. 2. Under the care of Cambridge University Hospitals CF team 3. Confirmed Cystic Fibrosis diagnosis 4. Uses an ineb as main nebulizer delivery device. 5. Parental/guardian permission (informed consent) and if appropriate, child assent. Exclusion Criteria: 1. Parents of CYP diagnosed with a CF screen positive inconclusive diagnosis (SPID). 2. If not yet doing lung function. 3. If has any other self-identified physical disability which may limit physical activity. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Cambridge University Hospitals NHS Foundation Trust |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | GPAQ | Activity questionnaire for parents | Reviews the past 7 days activities. | |
Secondary | CPAQ | Physical activity Questionnaire for children aged 5-11 (From medical notes) | Reviews the past 7 days activities. | |
Secondary | YPAQ | Physical activity Questionnaire for children aged 12 and over (From medical notes) | Reviews the past 7 days activities. | |
Secondary | Ineb adherence | Adherence to recommended number of nebulised treatment from the i-adhere software downloaded from the ineb device. | 1 year | |
Secondary | Lung function | FEV1 (z-score and %), FVC (z-score and %), FEF2575 (z-score and %) (From medical notes) | Best score in the last 1 year. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03637504 -
Feasibility of a Mobile Medication Plan Application in CF Patient Care
|
N/A | |
Active, not recruiting |
NCT04602468 -
Real World Clinical Outcomes With Novel Modulator Therapy Combinations in People With CF (RECOVER)
|
Phase 4 | |
Completed |
NCT06109675 -
Nutritional Status Assessment of Pediatric Cystic Fibrosis Patients and Effect of Nutrition Education on Nutritional Status
|
N/A | |
Active, not recruiting |
NCT04392544 -
Intestinal Inflammation in CF Patients
|
||
Completed |
NCT04084041 -
Efficacy of Simeox Airway Clearance Therapy in Children With Cystic Fibrosis
|
N/A | |
Not yet recruiting |
NCT03292718 -
Clinical Trial to Assess Influence of MyCyFAPP Use on GI Related QOL in Children With Cystic Fibrosis
|
N/A | |
Enrolling by invitation |
NCT06188988 -
Viral Infections and Airway Microbiome in Young Children With Cystic Fibrosis
|
||
Recruiting |
NCT04174664 -
Comparison of Different Functional Capacity Tests in Cystic Fibrosis Patients With Acute Pulmonary Exacerbation
|
||
Completed |
NCT04138589 -
Effect of Lumacaftor/Ivacaftor in Children With Cystic Fibrosis Homozygote for F508del on Small Airway Function
|
||
Completed |
NCT03579173 -
Determinants of Early Cystic Fibrosis Lung Disease
|
||
Recruiting |
NCT05850351 -
Virtual Reality Based Tele-Exercises on Exercise Capacity in Cystic Fibrosis
|
N/A | |
Completed |
NCT04463628 -
Impacts of the Covid-19 Epidemic and Associated Lockdown Measures on the Management, Health and Behaviors of Cystic Fibrosis Patients During the 2020 Epidemic
|
||
Completed |
NCT04835376 -
Percussion Palm Cup: Safety and Usability in Infants and Children With Cystic Fibrosis
|
N/A | |
Completed |
NCT04293926 -
Heart Rate Variability in Children and Adolescents With Cystic Fibrosis
|
N/A | |
Completed |
NCT04987567 -
Effect of Antioxidant Docosahexaenoic Acid (DHA) in Cystic Fibrosis Patients
|
N/A | |
Withdrawn |
NCT04415268 -
Combined Effect of CFTR Protein Modulator Drugs and Exercise in Cystic Fibrosis
|
N/A | |
Not yet recruiting |
NCT06066723 -
19F MRI in Healthy Children and Children With Mild Cystic Fibrosis Lung Disease
|
||
Terminated |
NCT03939065 -
Sensor Augmented Pump (SAP) Therapy for Inpatient CFRD Management
|
N/A | |
Active, not recruiting |
NCT04613128 -
The PROMISE Pediatric Study 6 to 11 Years Old
|
||
Completed |
NCT06242951 -
Cardiopulmonary Fitness in Children With Cystic Fibrosis Compared to Healthy Children
|